Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Their mission is to create new knowledge driven by data, computation, automation, and high-throughput robotics with the goal of fundamentally advancing the life sciences.

Prior to joining Strateos as Chief Business Officer, David Lynch held the role of VP of Business Development at Premier Research, a global clinical research organization, where he was tasked to develop, and implement commercial strategies to drive growth. Building and leading a team of business developers, he delivered exceptional growth doubling gross sales in less in 4 years. In the lab services segment, David was responsible for driving growth and market adoption within PPD’s lab division.

Previously, David held commercial leadership positions that contributed to the successful divestiture of two companies. Earlier in his career, David was a consultant with Arthur D. Little, a top management consultancy.

David holds a PhD in Microbiology and Infectious Diseases from the University of Pittsburgh, School of Public Health, and a BS from Syracuse University.